Clinical Trial Update: A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Yttrium-90 microsphere injection in combination with targeted immunotherapy for hepatocellular carcinoma, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 microsphere injection (yttrium-90 microspheres)

Snippet

Sponsor: GrandPharma (China) Co., Ltd. | Conditions: HCC | Phase 2 | Status: RECRUITING